805
Views
12
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Investigating strategies to reduce toxicity in stereotactic ablative radiotherapy for central lung tumors

, , &
Pages 330-335 | Received 19 May 2013, Accepted 16 Jul 2013, Published online: 20 Sep 2013

References

  • NCCN. Nccn clinical practice guildelines in oncology: Non-small cell lung cancer. Version 1.2013 . Available from: http://www.nccn.com. [cited 2012 Mar 1; 2013].
  • Senan S. Surgery versus stereotactic radiotherapy for patients with early-stage non-small cell lung cancer: More data from observational studies and growing clinical equipoise. Cancer 2013;119:2668–70.
  • Chi A, Liao Z, Nguyen NP, Xu J, Stea B, Komaki R. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications. Radiother Oncol 2010; 94:1–11.
  • Senthi S, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: A retrospective analysis. Lancet Oncol 2012;13:802–9.
  • Senthi S, Haasbeek CJ, Slotman BJ, Senan S. Outcomes of stereotactic ablative radiotherapy for central lung tumours: A systematic review. Radiother Oncol 2013;106:276–82.
  • Nuyttens JJ, van der Voort van Zyp NC, Praag J, Aluwini S, van Klaveren RJ, Verhoef C, et al. Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors. Radiother Oncol 2012;102:383–7.
  • Grills IS, Hope AJ, Guckenberger M, Kestin LL, Werner-Wasik M, Yan D, et al. A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy. J Thorac Oncol 2012; 7:1382–93.
  • Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, Gomi K, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004;101:1623–31.
  • Waldeland E, Ramberg C, Arnesen MR, Helland A, Brustugun OT, Malinen E. Dosimetric impact of a frame-based strategy in stereotactic radiotherapy of lung tumors. Acta Oncol 2012;51:603–9.
  • Hurkmans CW, Cuijpers JP, Lagerwaard FJ, Widder J, van der Heide UA, Schuring D, et al. Recommendations for implementing stereotactic radiotherapy in peripheral stage Ia non-small cell lung cancer: Report from the quality assurance working party of the randomised phase III Rosel study. Radiat Oncol 2009;4:1.
  • Hurkmans CW, van Lieshout M, Schuring D, van Heumen MJ, Cuijpers JP, Lagerwaard FJ, et al. Quality assurance of 4D-CT scan techniques in multicenter phase III trial of surgery versus stereotactic radiotherapy (radiosurgery or surgery for operable early stage (stage 1a) non-small-cell lung cancer [Rosel] study). Int J Radiat Oncol Biol Phys 2011;80:918–27.
  • Lu XQ, Shanmugham LN, Mahadevan A, Nedea E, Stevenson MA, Kaplan I, et al. Organ deformation and dose coverage in robotic respiratory-tracking radiotherapy. Int J Radiat Oncol Biol Phys 2008;71:281–9.
  • Wu J, Lei P, Shekhar R, Li H, Suntharalingam M, D’Souza WD. Do tumors in the lung deform during normal respiration? An image registration investigation. Int J Radiat Oncol Biol Phys 2009;75:268–75.
  • Keall PJ, Mageras GS, Balter JM, Emery RS, Forster KM, Jiang SB, et al. The management of respiratory motion in radiation oncology report of AAPM task group 76. Med Phys 2006;33:3874–900.
  • Baker R, Han G, Sarangkasiri S, DeMarco M, Turke C, Stevens CW, et al. Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung. Int J Radiat Oncol Biol Phys 2013;85:190–5.
  • Matsuo Y, Shibuya K, Nakamura M, Narabayashi M, Sakanaka K, Ueki N, et al. Dose-volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 2012;83:e545–9.
  • Bibault JE, Prevost B, Dansin E, Mirabel X, Lacornerie T, Lartigau E. Image-guided robotic stereotactic radiation therapy with fiducial-free tumor tracking for lung cancer. Radiat Oncol 2012;7:102.
  • Collins BT, Erickson K, Reichner CA, Collins SP, Gagnon GJ, Dieterich S, et al. Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors. Radiat Oncol 2007;2:39.
  • van der Voort van Zyp NC, Prevost JB, Hoogeman MS, Praag J, van der Holt B, Levendag PC, et al. Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: Clinical outcome. Radiother Oncol 2009;91:296–300.
  • Underberg RW, Lagerwaard FJ, Cuijpers JP, Slotman BJ, van Sornsen de Koste JR, Senan S. Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer. Int J Radiat Oncol Biol Phys 2004;60:1283–90.
  • van Dam IE, van Sornsen de Koste JR, Hanna GG, Muirhead R, Slotman BJ, Senan S. Improving target delineation on 4-dimensional CT scans in stage I NSCLC using a deformable registration tool. Radiother Oncol 2010;96:67–72.
  • Sim DG, Kwon OK, Park RH. Object matching algorithms using robust hausdorff distance measures. IEEE Trans Image Process 1999;8:425–9.
  • Persson GF, Nygaard DE, Brink C, Jahn JW, Munck AF Rosenschold P, Specht L, et al. Deviations in delineated GTV caused by artefacts in 4DCT. Radiother Oncol 2010;96:61–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.